About us Contacts Interactions: 118 620
Drug search by name

Calan (Verapamil Immediate-Release Tablets) and Hypertrophic cardiomyopathy

Result of checking the interaction of drug Calan (Verapamil Immediate-Release Tablets) and disease Hypertrophic cardiomyopathy for safety when used together.

Check result:
Calan (Verapamil Immediate-Release Tablets) <> Hypertrophic cardiomyopathy
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of verapamil in patients with hypertrophic cardiomyopathy, or idiopathic hypertrophic subaortic stenosis, has been associated with serious side effects such as pulmonary edema, severe hypotension, sinus bradycardia, AV block, sinus arrest, and death. However, a causal relationship has not been established. Therapy with verapamil should be administered cautiously in patients with hypertrophic cardiomyopathy. Dosage reduction or drug discontinuation may be required if severe adverse effects occur.

References:
  • "Product Information. Calan (verapamil)." Searle, Skokie, IL.
Calan (Verapamil Immediate-Release Tablets)

Generic Name: verapamil

Brand Name: Calan, Calan SR, Isoptin SR, Verelan, Isoptin, Isoptin IV, Covera-HS, Verelan PM

Synonyms: Calan Immediate-Release Tablets, Calan